LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 81.05 | 84.90 | 4757 | 8863 | 0.5367 | 0.8227 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 81.05 | 84.90 | 520 | 8863 | 0.0587 | 0.3103 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 81.05 | 84.90 | 6406 | 8863 | 0.7227 | 0.9055 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.75 | 84.90 | 4642 | 8621 | 0.5384 | 0.8226 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.75 | 84.90 | 4834 | 8621 | 0.5607 | 0.8337 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.75 | 84.90 | 586 | 8621 | 0.0680 | 0.3362 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.75 | 84.90 | 6467 | 8621 | 0.7501 | 0.9156 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.45 | 84.90 | 4538 | 8254 | 0.5497 | 0.8268 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.45 | 84.90 | 4871 | 8254 | 0.5901 | 0.8465 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.45 | 84.90 | 522 | 8254 | 0.0632 | 0.3166 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.45 | 84.90 | 6672 | 8254 | 0.8083 | 0.9366 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 86.16 | 84.90 | 4388 | 8141 | 0.5389 | 0.8208 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 86.16 | 84.90 | 4899 | 8141 | 0.6017 | 0.8515 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 86.16 | 84.90 | 576 | 8141 | 0.0707 | 0.3375 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 86.16 | 84.90 | 6813 | 8141 | 0.8368 | 0.9466 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.86 | 84.90 | 3796 | 7680 | 0.4943 | 0.7945 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.86 | 84.90 | 4853 | 7680 | 0.6319 | 0.8636 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.86 | 84.90 | 614 | 7680 | 0.0799 | 0.3559 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.86 | 84.90 | 7041 | 7680 | 0.9168 | 0.9734 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 89.57 | 84.90 | 2891 | 7494 | 0.3857 | 0.7260 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 89.57 | 84.90 | 4891 | 7494 | 0.6526 | 0.8722 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 89.57 | 84.90 | 640 | 7494 | 0.0854 | 0.3668 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 89.57 | 84.90 | 7219 | 7494 | 0.9632 | 0.9884 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 91.27 | 84.90 | 2574 | 7420 | 0.3469 | 0.6972 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 91.27 | 84.90 | 4851 | 7420 | 0.6538 | 0.8725 | MN20160318_Q02 | C03 |